TRVI
Trevi Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.48 / 10
Netural
Technical metrics aggregate to 5.48/10, illustrating mixed technical signals. Beneficial trends in Long Upper Shadow and Long Lower Shadow face opposition from MACD Golden Cross. Technical appraisal: neutral with watchful bias.
Analysis Checks(2/3)
Long Upper Shadow
Score7.18/10
Win Rate57.89%
Hist. Signals38
Avg Return2.86%
Score7.18/10
Win Rate57.89%
Hist. Signals38
Avg Return2.86%
MACD Golden Cross
Score2.87/10
Win Rate45.45%
Hist. Signals11
Avg Return-0.16%
Score2.87/10
Win Rate45.45%
Hist. Signals11
Avg Return-0.16%
Long Lower Shadow
Score6.38/10
Win Rate52.50%
Hist. Signals40
Avg Return2.29%
Score6.38/10
Win Rate52.50%
Hist. Signals40
Avg Return2.29%
Long Upper Shadow
Score7.18/10
Win Rate57.89%
Hist. Signals38
Avg Return2.86%
Score7.18/10
Win Rate57.89%
Hist. Signals38
Avg Return2.86%
Long Lower Shadow
Score6.38/10
Win Rate52.50%
Hist. Signals40
Avg Return2.29%
Score6.38/10
Win Rate52.50%
Hist. Signals40
Avg Return2.29%
MACD Golden Cross
Score2.87/10
Win Rate45.45%
Hist. Signals11
Avg Return-0.16%
Score2.87/10
Win Rate45.45%
Hist. Signals11
Avg Return-0.16%
What is the current technical signals for TRVI?
- TRVI presents a Netural setup with a Technical Score of 5.48/10. Key technical indicators highlight an RSI of 52.79 and a MACD of 0.29, with the trend anchored by the 50-Day SMA at 11.94. Traders should monitor key support at 10.46 and resistance at 11.67.
